scorecardresearch
Friday, March 29, 2024
TopicPharma sector

Topic: Pharma sector

Govt looks to boost domestic production of raw ingredients for medicines, revises guidelines

The govt has changed certain criteria under its Production-Linked Incentive scheme that was approved in March to reduce dependence on China.

Test efficacy of umifenovir alone as Covid drug, not with favipiravir — govt panel to Macleods

Mumbai-based Macleods Pharmaceuticals had sought permission to conduct clinical trials on umifenovir, a Russian drug used to treat influenza.

Modi govt to form standing committee to prevent drugmakers from evading price control

Representatives from NPPA, CDSCO and DGHS to be part of the standing committee, which will have mandate to approve the drug discontinuation applications.

Himachal drug firm under scanner again after cough syrup causes ‘kidney failure’ in 2-yr-old

Himachal-based Digital Vision was earlier booked by state govt in February for selling another contaminated syrup, which led to 9 infant deaths in J&K and one in Haryana.

Depending on China for imports could threaten India’s drug security: Export council DG

Udaya Bhaskar, Director-General of Pharmexcil, says India’s over-dependence on China for its bulk drugs requirement led to fall in exports in February and March.

Face scan, open doors, zig-zag seating, doctor-on-call: Pharma firms redefine Covid workplace

The pharmaceutical industry has functioned throughout the lockdown and as such is leading the way in creating a safe workplace amid Covid-19 pandemic. 

Why India saw only 4 pharma products launched in April, its lowest count ever

The pharma industry has seen a fall of about 99% in new product launches since April 2019, when 349 products were launched.

Indian drugmakers begin developing remdesivir, ‘world’s best shot’ against Covid-19

In a trial involving monkeys, early treatment of Covid-19 with remdesivir has shown to reduce symptoms of the disease and lung damage. 

Modi govt allows pharma firms to tweak clinical trial rules during Covid-19 lockdown

Over 2,500 active trials are said to be underway in India for drugs aimed at patients suffering from cancer and hepatitis B, among other things.

Govt gives Rs 15,000-cr boost to API and devices industry to check shortage amid COVID-19

The government hasn’t yet announced details of the policy, which seeks to make India self-reliant in the manufacturing of bulk drugs.   

On Camera

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.